Manuel de la Mata

3.1k total citations
53 papers, 1.4k citations indexed

About

Manuel de la Mata is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Manuel de la Mata has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 21 papers in Surgery and 19 papers in Epidemiology. Recurrent topics in Manuel de la Mata's work include Liver Disease and Transplantation (21 papers), Organ Transplantation Techniques and Outcomes (16 papers) and Liver Disease Diagnosis and Treatment (16 papers). Manuel de la Mata is often cited by papers focused on Liver Disease and Transplantation (21 papers), Organ Transplantation Techniques and Outcomes (16 papers) and Liver Disease Diagnosis and Treatment (16 papers). Manuel de la Mata collaborates with scholars based in Spain, Bulgaria and United States. Manuel de la Mata's co-authors include Antoni Mas, Àngels Escorsell, Trinidad Serrano, Gustavo Ferrín, Francisco Suárez, Pedro López‐Cillero, Miquel Navasa, Antoni Rimola, Montserrat Garcı́a-Retortillo and Anna Feliu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Manuel de la Mata

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel de la Mata Spain 20 916 692 409 201 142 53 1.4k
Pedro López‐Cillero Spain 18 393 0.4× 242 0.3× 373 0.9× 128 0.6× 50 0.4× 50 769
Gert Judmaier Austria 11 577 0.6× 574 0.8× 146 0.4× 146 0.7× 69 0.5× 11 1.1k
André Geubel Belgium 20 681 0.7× 560 0.8× 527 1.3× 135 0.7× 315 2.2× 82 1.5k
Alişan Kahraman Germany 19 545 0.6× 900 1.3× 300 0.7× 294 1.5× 76 0.5× 62 1.4k
Sen Zhong China 18 382 0.4× 477 0.7× 161 0.4× 231 1.1× 61 0.4× 67 1.3k
Gerald Denk Germany 23 615 0.7× 647 0.9× 504 1.2× 215 1.1× 190 1.3× 63 1.5k
Melanie Beaton Canada 20 684 0.7× 1.3k 1.9× 281 0.7× 312 1.6× 104 0.7× 41 1.9k
R Enat Israel 15 448 0.5× 304 0.4× 294 0.7× 204 1.0× 79 0.6× 42 965
Takehiro Fujii Japan 13 308 0.3× 307 0.4× 394 1.0× 320 1.6× 67 0.5× 69 1.1k
Adam Sheka United States 12 334 0.4× 898 1.3× 344 0.8× 315 1.6× 21 0.1× 21 1.3k

Countries citing papers authored by Manuel de la Mata

Since Specialization
Citations

This map shows the geographic impact of Manuel de la Mata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel de la Mata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel de la Mata more than expected).

Fields of papers citing papers by Manuel de la Mata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel de la Mata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel de la Mata. The network helps show where Manuel de la Mata may publish in the future.

Co-authorship network of co-authors of Manuel de la Mata

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel de la Mata. A scholar is included among the top collaborators of Manuel de la Mata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel de la Mata. Manuel de la Mata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gourlay, Annabelle, et al.. (2024). Gender-transformative HIV and SRHR programme approaches for adolescents and young people: a realist review to inform policy and programmes. BMJ Global Health. 9(12). e014363–e014363. 2 indexed citations
2.
Ciria, Rubén, Javier Caballero‐Villarraso, Gustavo Ferrín, et al.. (2019). Bevacizumab Allows Preservation of Liver Function and its Regenerative Capacity after Major Hepatectomy. Anti-Cancer Agents in Medicinal Chemistry. 19(11). 1388–1398. 2 indexed citations
3.
Amado, Víctor, Manuel Rodríguez‐Perálvarez, Gustavo Ferrín, & Manuel de la Mata. (2018). Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria. SHILAP Revista de lepidopterología. Volume 6. 1–10. 22 indexed citations
4.
Castells, Lluı́s, Sonia Pascual, Iratxe Díez Miranda, et al.. (2017). The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study. Gastroenterología y Hepatología. 40(8). 515–524. 8 indexed citations
5.
Rodríguez‐Perálvarez, Manuel, et al.. (2017). Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact. PLoS ONE. 12(4). e0175010–e0175010. 11 indexed citations
6.
López‐Sánchez, Laura M., Juan R. Muñoz‐Castañeda, Manuel Rodríguez‐Perálvarez, et al.. (2015). GCDCA down-regulates gene expression by increasing Sp1 binding to the NOS-3 promoter in an oxidative stress dependent manner. Biochemical Pharmacology. 96(1). 39–51. 17 indexed citations
7.
Ferrín, Gustavo, et al.. (2015). Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. PubMed. 7. 1–1. 37 indexed citations
8.
Herencia, Carmen, Antonio Rodríguez‐Ariza, Antonio Canalejo, et al.. (2011). Differential Bone Marrow Hematopoietic Stem Cells Mobilization in Hepatectomized Patients. Journal of Gastrointestinal Surgery. 15(8). 1459–1467. 6 indexed citations
9.
González, Raúl, Adolfo Cruz, Gustavo Ferrín, et al.. (2011). Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids. Journal of Hepato-Biliary-Pancreatic Sciences. 18(5). 740–750. 18 indexed citations
10.
González, Raúl, Gustavo Ferrín, Ana B. Hidalgo, et al.. (2009). N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes. Chemico-Biological Interactions. 181(1). 95–106. 59 indexed citations
11.
Romero‐Gómez, Manuel, M. Diago, Raúl J. Andrade, et al.. (2009). Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin†‡. Hepatology. 50(6). 1702–1708. 112 indexed citations
12.
Briceño, Javier, Juan Manuel Sánchez‐Hidalgo, Rubén Ciria, et al.. (2008). Model for End-stage Liver Disease Can Predict Very Early Outcome After Liver Transplantation. Transplantation Proceedings. 40(9). 2952–2954. 7 indexed citations
13.
López‐Sánchez, Laura M., Fernando J. Corrales, Raúl González, et al.. (2008). Alteration of S‐nitrosothiol homeostasis and targets for protein S‐nitrosation in human hepatocytes. PROTEOMICS. 8(22). 4709–4720. 24 indexed citations
14.
Escorsell, Àngels, Antoni Mas, & Manuel de la Mata. (2007). Acute Liver Failure in Spain. Liver Transplantation. 13(10). 1389–1395. 139 indexed citations
15.
16.
Mata, Manuel de la, Natividad Cuende, A Bernardos, et al.. (2006). Model for End-Stage Liver Disease Score-Based Allocation of Donors for Liver Transplantation: A Spanish Multicenter Experience. Transplantation. 82(11). 1429–1435. 37 indexed citations
17.
González, Rafael Arroyo, et al.. (2000). Levels of HBV‐DNA and HBsAg after acute liver allograft rejection treatment by corticoids and OKT3. Clinical Transplantation. 14(3). 208–211. 8 indexed citations
18.
Soriano, Sagrario, et al.. (1999). Long-term results of combined kidney and liver transplantation in patients with nephropaty associated with liver disease. Transplantation Proceedings. 31(6). 2306–2307. 6 indexed citations
19.
Riestra, Sabino, Manuel Rodríguez, Manuel Delgado, et al.. (1998). Tamoxifen Does Not Improve Survival of Patients With Advanced Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 26(3). 200–203. 47 indexed citations
20.
Cuervas‐Mons, Valentín, Manuel de la Mata, Enrique Fraga, et al.. (1998). OUTCOME OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION1. Transplantation. 66(12). 1645–1650. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro López‐Cillero Breakdown of academic impact, for papers by Gert Judmaier Breakdown of academic impact, for papers by André Geubel Breakdown of academic impact, for papers by Alişan Kahraman Breakdown of academic impact, for papers by Sen Zhong Breakdown of academic impact, for papers by Gerald Denk Breakdown of academic impact, for papers by Melanie Beaton Breakdown of academic impact, for papers by R Enat Breakdown of academic impact, for papers by Takehiro Fujii Breakdown of academic impact, for papers by Adam Sheka
Rankless by CCL
2026